Lansdale, PA, United States of America

Alex L Harris

This inventor holds 1 USPTO granted patent. Top assignee: Sterling Winthrop Inc.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex L Harris - Innovator in Calpain Inhibitors

Introduction

Alex L Harris is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of calpain inhibitors. His innovative work has led to the creation of a unique compound that holds promise for various therapeutic applications.

Latest Patents

Alex L Harris holds a patent for a compound known as quinolone carboxamide calpain inhibitors. This compound is characterized by a specific formula wherein Z can be aryl, substituted aryl, phenyl-lower-alkyl, hetero-aryl, substituted heteroaryl, heterocycloalkyl, heterocyclocalkyl-lower-alkyl, or hetero-aryl-lower-alkyl. The invention highlights the potential for one or more hydrogens of aryl and heteroaryl to be replaced by specific groups A and B, showcasing the compound's versatility and application in medical research.

Career Highlights

Throughout his career, Alex has been associated with Sterling Winthrop Inc., where he has contributed to various research initiatives. His work has not only advanced the understanding of calpain inhibitors but has also paved the way for new therapeutic strategies in treating diseases related to calpain activity.

Collaborations

Alex has collaborated with several esteemed colleagues, including Roland Ellwood Dolle and Todd L Graybill. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.

Conclusion

In summary, Alex L Harris is a distinguished inventor whose work in calpain inhibitors has made a significant impact in the pharmaceutical industry. His innovative spirit and collaborative efforts continue to drive advancements in medical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…